These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7720329)

  • 1. Treatment of Stevens-Johnson syndrome with pooled human intravenous immune globulin.
    Moudgil A; Porat S; Brunnel P; Jordan SC
    Clin Pediatr (Phila); 1995 Jan; 34(1):48-51. PubMed ID: 7720329
    [No Abstract]   [Full Text] [Related]  

  • 2. Stevens-Johnson syndrome after mycoplasma pneumoniae infection.
    Tsai V; Oman J
    J Emerg Med; 2011 Mar; 40(3):324-7. PubMed ID: 18614318
    [No Abstract]   [Full Text] [Related]  

  • 3. Acute hemolysis secondary to high-dose intravenous immunoglobulin in a patient with Stevens-Johnson syndrome.
    Shakouri AA; Bahna SL
    Ann Allergy Asthma Immunol; 2012 Jun; 108(6):463-4. PubMed ID: 22626604
    [No Abstract]   [Full Text] [Related]  

  • 4. High-dose i.v. 7S immunoglobulin treatment in Stevens-Johnson syndrome.
    Cazzola G; Nicolussi M; Carraro F; Cavalieri S; Graziani MS
    Helv Paediatr Acta; 1986 May; 41(1-2):87-8. PubMed ID: 3721900
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of intravenous immunoglobulin for Stevens-Johnson syndrome and toxic epidermal necrolysis in children: Report of two cases secondary to anticonvulsants.
    Romero-Tapia SJ; Cámara-Combaluzier HH; Baeza-Bacab MA; Cerino-Javier R; Bulnes-Mendizabal DP; Virgen-Ortega C
    Allergol Immunopathol (Madr); 2015; 43(2):227-9. PubMed ID: 25183634
    [No Abstract]   [Full Text] [Related]  

  • 6. Leukocyte bound gamma-globulin in patients with Stevens-Johnson syndrome.
    Watanabe N
    Paediatr Univ Tokyo; 1968 Jan; 15():41-3. PubMed ID: 4175256
    [No Abstract]   [Full Text] [Related]  

  • 7. [Response to the comment on the contribution "Successful therapy of Lyell syndrome with intravenous immunoglobulins"].
    Mockenhaupt M
    Hautarzt; 2000 Feb; 51(2):106-7. PubMed ID: 10743583
    [No Abstract]   [Full Text] [Related]  

  • 8. [Use of high dose intravenous immunoglobulins in dermatology].
    Mockenhaupt M; Roujeau JC
    J Dtsch Dermatol Ges; 2010 May; 8(5):386-7; author reply 387-9. PubMed ID: 20537010
    [No Abstract]   [Full Text] [Related]  

  • 9. Ophthalmic complications and management of Stevens-Johnson syndrome at a tertiary eye care centre in south India.
    Kompella VB; Sangwan VS; Bansal AK; Garg P; Aasuri MK; Rao GN
    Indian J Ophthalmol; 2002 Dec; 50(4):283-6. PubMed ID: 12532492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature.
    Letko E; Papaliodis DN; Papaliodis GN; Daoud YJ; Ahmed AR; Foster CS
    Ann Allergy Asthma Immunol; 2005 Apr; 94(4):419-36; quiz 436-8, 456. PubMed ID: 15875523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous immune globulin therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis complicated by hemolysis leading to pigment nephropathy and hemodialysis.
    Ririe MR; Blaylock RC; Morris SE; Jung JY
    J Am Acad Dermatol; 2013 Aug; 69(2):221-5. PubMed ID: 23673282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experience with the use of hemosorption in the intensive therapy of Stevens-Johnson syndrome in a child].
    Vozgoment OV; Griaznov VN; Medvedev SL
    Anesteziol Reanimatol; 1989; (6):46-7. PubMed ID: 2629542
    [No Abstract]   [Full Text] [Related]  

  • 13. [Stevens-Johnson syndrome associated with Mycoplasma pneumoniae infection in an adult].
    Iwata M; Tano M; Ikuta N; Inagaki T; Suzuki S; Kondo M; Naito Y; Matsumoto S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Jan; 29(1):89-94. PubMed ID: 2041264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress in the understanding of hypersensitivity drug reactions.
    Blanca M; Thong BY
    Curr Opin Allergy Clin Immunol; 2013 Aug; 13(4):321-2. PubMed ID: 23770682
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasmapheresis as adjuvant therapy in Stevens-Johnson syndrome and hepatic encephalopathy.
    Hung PC; Wang HS; Hsia SH; Wong AM
    Brain Dev; 2014 Apr; 36(4):356-8. PubMed ID: 23777679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The timing of intravenous immunoglobulin therapy in Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Yeung CK; Lam LK; Chan HH
    Clin Exp Dermatol; 2005 Sep; 30(5):600-2. PubMed ID: 16045716
    [No Abstract]   [Full Text] [Related]  

  • 17. [Stevens-Johnson syndrome].
    Mouillon M; Romanet JP; Lafont D
    Bull Soc Ophtalmol Fr; 1982; 82(6-7):867-76. PubMed ID: 7172387
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comment on the report "Successful treatment of Lyell's syndrome with intravenous immunoglobulins". ("Gehört-gelesen-nachgefragt") Hautarzt (1998) 49:950-951].
    Mockenhaupt M; Schröder W
    Hautarzt; 1999 Jul; 50(7):513-4. PubMed ID: 10464687
    [No Abstract]   [Full Text] [Related]  

  • 19. Stevens-Johnson syndrome: a pediatric experience.
    Shum S
    J La State Med Soc; 1976 Dec; 128(12):331-3. PubMed ID: 1018158
    [No Abstract]   [Full Text] [Related]  

  • 20. Management of Stevens-Johnson syndrome.
    Crosby SS; Murray KM; Marvin JA; Heimbach DM; Tartaglione TA
    Clin Pharm; 1986 Aug; 5(8):682-9. PubMed ID: 3742953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.